GPC3 and hepatocellular carcinoma: Addition of CXCR2 expression by GPC3-targeted CAR T cells has previously been shown to increase homing and produce greater in vivo anti-tumoral effects in a mouse xenograft model of hepatocellular carcinoma (HCC) [42].